AlloDerm + Emdogain

This combination therapy consists of **AlloDerm** (a regenerative tissue matrix) and **Emdogain** (an enamel matrix derivative) used for the treatment of gingival recession. AlloDerm, manufactured by BioHorizons, is an acellular dermal matrix (ADM) derived from human cadaveric tissue that has been processed to remove cells while preserving a bioactive collagen scaffold. It serves as a structural framework for host cell migration and tissue ingrowth. Emdogain, manufactured by Straumann, is a biologic product containing porcine-derived enamel matrix proteins, primarily amelogenins. These proteins trigger the biological processes of natural tooth development, promoting the regeneration of periodontal attachment, including cementum, periodontal ligament, and alveolar bone. In clinical trials conducted at the **University of Louisville**, this combination is typically applied using a coronally positioned tunnel technique to achieve root coverage and increase keratinized tissue width in patients with Miller class 1 or 2 gingival recession.

Brand names

AlloDermEmdogain

Other names

Regenerative tissue matrix + enamel matrix derivativeAcellular dermal matrix + enamel matrix derivativeAlloDerm RTM + Enamel Matrix Derivative